Why did the scale-up of HIV treatment work?: A case example from Malawi

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue SUPPL. 2, 2011, Pages

  Harries, Anthony D ^a,b,e   Makombe, Simon D ^c   Libamba, Edwin ^c   Schouten, Erik J ^c,d  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c MINISTRY OF HEALTH   (Malawi)

^d Management Sciences for Health ^*  (Malawi)

^e Old Inn Cottage   (United Kingdom)

Author keywords

Africa; antiretroviral therapy; health systems; HIV; Malawi

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

ARTICLE; EPIDEMIC; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALAWI; MEDICAL RECORD; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCALE UP; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; CHILD; DEVELOPING COUNTRIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; INTERNATIONAL COOPERATION; MALAWI; MALE; ORGANIZATIONAL CASE STUDIES; PUBLIC HEALTH; TUBERCULOSIS, PULMONARY;

EID: 79959971773     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821f6bab     Document Type: Article

References (21)

1. Population and Housing Census 2008. Preliminary Report. Zomba, Malawi: National Statistics Office; 2008.
2. National AIDS Commission. National Estimates of HIV/AIDS in Malawi. Lilongwe, Malawi: National AIDS Commission; 2005.
3. Department of HIVand AIDS, Ministry of Health. Quarterly Report of the Antiretroviral Treatment Programme in Malawi With results up to 30th June .2010. Lilongwe,Malawi: Department of HIVand AIDS,Ministry of Health.
4. van Oosterhout JJG, Luafer MK, Graham SM, et al. A community-based study of the incidence of trimethoprim-sulfamethoxazole preventable infections in Malawian adults living with HIV. J Acquir Immune Defic Syndr. 2005;39:626-631. (Pubitemid 41098481)
5. Jahn A, Floyd S, Crampin AC, et al. Population level-effect of HIV on adult mortality and early evidence of reversal following roll-out of antiretroviral therapy in Malawi. Lancet. 2008;371:1603-1611. (Pubitemid 351626844)
6. Mwagomba B, Zachariah R, Massaquoi M, et al. Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS One. 2010;5:e10452.
7. World Health Organization (WHO). Treating 3 Million by 2005: Making It Happen: The WHO Strategy. Geneva, Switzerland: WHO and the Joint United Nations Program on HIV/AIDS (UNAIDS); 2003.
8. Lee JW. Global health improvement and WHO: shaping the future. Lancet. 2003;362:2083-2088.
9. World Health Organization. WHO Tuberculosis Programme. Framework for Effective Tuberculosis Control. Geneva: World Health Organization; .1994. WHO/TB/94.179.
10. Ministry of Health, Malawi. Treatment of AIDS. Guidelines for the Use of Antiretroviral Therapy in Malawi. 1st ed. Lilongwe, Malawi: Ministry of Health, Malawi; 2003.
11. Ministry of Health, Malawi. Treatment of AIDS. Guidelines for the Use of Antiretroviral Therapy in Malawi. 2nd ed. Lilongwe, Malawi: Ministry of Health, Malawi; 2006.
12. Libamba E, Makombe S, Mhango E, et al. Supervision, monitoring, and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull World Health Organ. 2006;84:320-326.
13. Makombe SD, Hochgesang M, Jahn A, et al. Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi. Bull World Health Organ. 2008;86:310-314. (Pubitemid 351521858)
14. Makombe SD, Jahn A, Tweya H, et al. A national survey of the impact of rapid scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival. Bull World Health Organ. 2007; 85:851-857. (Pubitemid 350086457)
15. Lowrance D, Makombe S, Harries A, et al. Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi. J Acquir Immune Defic Syndr. 2007;46:56-61. (Pubitemid 47507434)
16. Harries AD, Schouten EJ, Makombe SD, et al. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ. 2007;85:152-155.
17. Van DammeW, Kober K, Laga M. The real challenges for scaling up ART in sub-Saharan Africa. AIDS. 2006;20:653-656. (Pubitemid 43884291)
18. Harries AD, Zachariah R, van Oosterhout JJ, et al. Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis. 2010;10:60-65.
19. Harries AD, Zachariah R, Corbett EL, et al. The HIV-associated tuberculosis epidemic-when will we act? Lancet. 2010;375: 1906-1919.
20. Douglas GP, Gadabu OJ, Joukes S, et al. Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med. 2010;7:e1000319.
21. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009:373:48-57.